Voyager Therapeutics Inc. (VYGR) Soars 5.58% on November 19 – Equities.com

Related Articles:

• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• Voyager Therapeutics Inc. (VYGR) Soars 11.7% on March 15 - Equities.com March 15, 2019 Voyager Therapeutics Inc. (VYGR) Soars 11.7% on March 15  Equities.comVoyager Therapeutics Inc. is a Voyager Therapeutics Inc is functional in the United States biotechnology industry. Last Price $ 19.66, Last Trade Mar/15 - 16:00.
• Voyager Therapeutics Inc. (VYGR) Soars 7.38% on April 02 - Equities.com April 2, 2019 Voyager Therapeutics Inc. (VYGR) Soars 7.38% on April 02  Equities.comVoyager Therapeutics Inc. is a Voyager Therapeutics Inc is functional in the United States biotechnology industry. Last Price $ 21.25, Last Trade Apr/02 - 16:00.
• Voyager Therapeutics Inc. (VYGR) Soars 7.2% on November 20 - Equities.com November 20, 2019 Voyager Therapeutics Inc. (VYGR) Soars 7.2% on November 20  Equities.com
• Monthly Research Review – November 2019 November 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during November 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Voyager Therapeutics Inc. (VYGR) Soars 5.26% on December 14 - Equities.com December 14, 2020 Voyager Therapeutics Inc. (VYGR) Soars 5.26% on December 14  Equities.com
• Voyager Therapeutics Inc. (VYGR) Soars 1.82% on December 30 - Equities.com December 30, 2020 Voyager Therapeutics Inc. (VYGR) Soars 1.82% on December 30  Equities.com
• Voyager Therapeutics Inc. (VYGR) Soars 1.54% on January 04 - Equities.com January 4, 2021 Voyager Therapeutics Inc. (VYGR) Soars 1.54% on January 04  Equities.com
• Voyager Therapeutics Inc. (VYGR) Soars 3.08% on January 12 - Equities.com January 12, 2021 Voyager Therapeutics Inc. (VYGR) Soars 3.08% on January 12  Equities.com
• Voyager Therapeutics Inc. (VYGR) Soars 2% on January 19 - Equities.com January 19, 2021 Voyager Therapeutics Inc. (VYGR) Soars 2% on January 19  Equities.com
• Voyager Therapeutics Inc. (VYGR) Soars 2.31% on January 20 - Equities.com January 20, 2021 Voyager Therapeutics Inc. (VYGR) Soars 2.31% on January 20  Equities.com
• Voyager Therapeutics Inc. (VYGR) Plunges 5.71% on March 12 - Equities.com March 12, 2019 Voyager Therapeutics Inc. (VYGR) Plunges 5.71% on March 12  Equities.comVoyager Therapeutics Inc. is a Voyager Therapeutics Inc is functional in the United States biotechnology industry. Last Price $ 17.51, Last Trade Mar/12 - 16:00.
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
• Voyager Therapeutics Inc. (VYGR) Plunges 7.55% on November 04 - Equities.com November 4, 2019 Voyager Therapeutics Inc. (VYGR) Plunges 7.55% on November 04  Equities.com
• Parkinson's Disease News - Editor's Picks (Archive 2016.11) March 17, 2017 Newsfeed: PD News PD Research News PD Fitness News PD Boxing News PD Web Articles PD Blogs PD Editor's Picks PD Twitter Newsfeed Neurons Paralyze Us During REM SleepIt will also be most useful in the study of Parkinson’s disease, since these pathologies are related. This work was published on December 12, 2016 on the website of the journal Brain.…
• Monthly Research Review – September 2019 September 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Voyager Therapeutics Inc. (VYGR) Plunges 5.45% on December 24 - Equities.com December 24, 2020 Voyager Therapeutics Inc. (VYGR) Plunges 5.45% on December 24  Equities.com
• Voyager Therapeutics Inc. (VYGR) Plunges 5.45% on December 25 - Equities.com December 25, 2020 Voyager Therapeutics Inc. (VYGR) Plunges 5.45% on December 25  Equities.com
• Voyager Therapeutics Inc. (VYGR) Plunges 5.05% on December 29 - Equities.com December 29, 2020 Voyager Therapeutics Inc. (VYGR) Plunges 5.05% on December 29  Equities.com
• Minerva Neurosciences Inc (NERV) Soars 5.16% on November 05 - Equities.com November 5, 2019 Minerva Neurosciences Inc (NERV) Soars 5.16% on November 05  Equities.com
• Neurocrine, Voyager Team Up to Develop VY-AADC for Parkinson’s Disease February 4, 2019 Neurocrine Biosciences and Voyager Therapeutics have joined efforts in a new strategic collaboration to further develop and market Voyager’s gene therapies VY-AADC for Parkinson’s disease and VY-FXN01 for Friedreich’s ataxia. With this partnership, Neurocrine Biosciences will apply its expertise in neuroscience, drug development, and commercialization to help expedite the development of Voyager’s gene therapy programs. “We are excited to collaborate…
• Voyager Recruits Patients for Phase 1 Trial Testing VY-AADC01 Gene Therapy Delivery November 21, 2017 Voyager Therapeutics announced it’s recruiting participants for the company’s new Phase 1 clinical trial to test a new approach for their gene therapy VY-AADC01 in Parkinson’s disease patients. The company has also released updates to its ongoing Phase 1b trial testing VY-AADC01 and highlighted its preclinical programs focusing on amyotrophic lateral sclerosis, Huntington’s disease, and Friedreich’s ataxia. AAV is a small virus capable…